89 related articles for article (PubMed ID: 28352771)
1. Negative regulation of CDC42 expression and cell cycle progression by miR-29a in breast cancer.
Zhang M; Guo W; Qian J; Wang B
Open Med (Wars); 2016; 11(1):78-82. PubMed ID: 28352771
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-29a functions as a potential tumor suppressor through directly targeting CDC42 in non-small cell lung cancer.
Li Y; Wang Z; Li Y; Jing R
Oncol Lett; 2017 May; 13(5):3896-3904. PubMed ID: 28521487
[TBL] [Abstract][Full Text] [Related]
3. The inhibitory role of Mir-29 in growth of breast cancer cells.
Wu Z; Huang X; Huang X; Zou Q; Guo Y
J Exp Clin Cancer Res; 2013 Dec; 32(1):98. PubMed ID: 24289849
[TBL] [Abstract][Full Text] [Related]
4. miR-29a Negatively Affects Glucose-Stimulated Insulin Secretion and MIN6 Cell Proliferation via Cdc42/
Duan J; Qian XL; Li J; Xiao XH; Lu XT; Lv LC; Huang QY; Ding W; Zhang HY; Xiong LX
Int J Endocrinol; 2019; 2019():5219782. PubMed ID: 31662747
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of miR-25 modulates non-small cell lung cancer cells by targeting CDC42.
Yang T; Chen T; Li Y; Gao L; Zhang S; Wang T; Chen M
Tumour Biol; 2015 Mar; 36(3):1903-11. PubMed ID: 25432132
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-29a inhibits cell proliferation and arrests cell cycle by modulating p16 methylation in cervical cancer.
Wang A; Xu Q; Sha R; Bao T; Xi X; Guo G
Oncol Lett; 2021 Apr; 21(4):272. PubMed ID: 33717269
[TBL] [Abstract][Full Text] [Related]
7. miR-29a up-regulation in AR42J cells contributes to apoptosis via targeting TNFRSF1A gene.
Fu Q; Qin T; Chen L; Liu CJ; Zhang X; Wang YZ; Hu MX; Chu HY; Zhang HW
World J Gastroenterol; 2016 May; 22(20):4881-90. PubMed ID: 27239114
[TBL] [Abstract][Full Text] [Related]
8. miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells.
Liu M; Lang N; Qiu M; Xu F; Li Q; Tang Q; Chen J; Chen X; Zhang S; Liu Z; Zhou J; Zhu Y; Deng Y; Zheng Y; Bi F
Int J Cancer; 2011 Mar; 128(6):1269-79. PubMed ID: 20473940
[TBL] [Abstract][Full Text] [Related]
9. Inhibiting MicroRNA-29a Protects Myocardial Ischemia-Reperfusion Injury by Targeting SIRT1 and Suppressing Oxidative Stress and NLRP3-Mediated Pyroptosis Pathway.
Ding S; Liu D; Wang L; Wang G; Zhu Y
J Pharmacol Exp Ther; 2020 Jan; 372(1):128-135. PubMed ID: 31481517
[TBL] [Abstract][Full Text] [Related]
10. MiR-29a promotes cell proliferation and EMT in breast cancer by targeting ten eleven translocation 1.
Pei YF; Lei Y; Liu XQ
Biochim Biophys Acta; 2016 Nov; 1862(11):2177-2185. PubMed ID: 27555295
[TBL] [Abstract][Full Text] [Related]
11. Long Non-Coding RNA Taurine Upregulated Gene 1 (TUG1) Downregulation Constrains Cell Proliferation and Invasion through Regulating Cell Division Cycle 42 (CDC42) Expression Via MiR-498 in Esophageal Squamous Cell Carcinoma Cells.
Wang Z; Liu J; Wang R; Wang Q; Liang R; Tang J
Med Sci Monit; 2020 Mar; 26():e919714. PubMed ID: 32139664
[TBL] [Abstract][Full Text] [Related]
12. MiR-155 promotes the proliferation and migration of breast cancer cells via targeting SOCS1 and MMP16.
Zhang W; Chen CJ; Guo GL
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7323-7332. PubMed ID: 30468477
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-154 inhibits growth and invasion of breast cancer cells through targeting E2F5.
Xu H; Fei D; Zong S; Fan Z
Am J Transl Res; 2016; 8(6):2620-30. PubMed ID: 27398145
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of anti-miR29a in breast cancer patients with type 2 diabetes: an
Li Z; Min L; Chen L; Hu Y; Luan W; Li C; Xiong Q; Huang K
Transl Cancer Res; 2022 May; 11(5):1285-1296. PubMed ID: 35706821
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of microRNA-29a regulates the expression of apoptosis-related genes in MCF-7 breast carcinoma cells.
Khamisipour G; Mansourabadi E; Naeimi B; Moazzeni A; Tahmasebi R; Hasanpour M; Mohammadi MM; Mansourabadi Z; Shamsian S
Mol Clin Oncol; 2018 Feb; 8(2):362-369. PubMed ID: 29435304
[TBL] [Abstract][Full Text] [Related]
17. miR-29a inhibits proliferation, invasion, and migration of papillary thyroid cancer by targeting DPP4.
Wang Y; Han J; Lv Y; Zhang G
Onco Targets Ther; 2019; 12():4225-4233. PubMed ID: 31213841
[No Abstract] [Full Text] [Related]
18. MicroRNA-29a plays a suppressive role in non-small cell lung cancer cells via targeting LASP1.
Hu Z; Cui Y; Zhou Y; Zhou K; Qiao X; Li C; Wang S
Onco Targets Ther; 2016; 9():6999-7009. PubMed ID: 27895492
[TBL] [Abstract][Full Text] [Related]
19. MiR-1301-3p inhibits human breast cancer cell proliferation by regulating cell cycle progression and apoptosis through directly targeting ICT1.
Peng X; Yan B; Shen Y
Breast Cancer; 2018 Nov; 25(6):742-752. PubMed ID: 29951881
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis.
Maurer B; Stanczyk J; Jüngel A; Akhmetshina A; Trenkmann M; Brock M; Kowal-Bielecka O; Gay RE; Michel BA; Distler JH; Gay S; Distler O
Arthritis Rheum; 2010 Jun; 62(6):1733-43. PubMed ID: 20201077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
